戻る Agendas
Session 0401 Statistical Methods for Oncology Clinical Trials
Session Chair(s)
Ouhong Wang, PHD, MBA
Vice President, Biostatistics
Vertex Pharmaceuticals, United States
Speaker(s)
An Adaptive Seamless Phase IIIII Design for Oncology Trials with Subpopulation Selection Using Correlated Survival Endpoints
Jerry Wu
Amgen, China
Manager, Biostatistics
Flexible Modelling of Survival Curves for Censored Data in Oncology Trial
Steve Su
Covance, Australia, China
Senior Biostatistician, Statistics and Programmin
Interval-censoring and its applications to oncology endpoint
Chao Zhu
Lilly Suzhou Pharmaceutical Co. Ltd., China, China
Head of Medical Science at Lilly China Drug Development and Medical Affairs Cent
Statistical Considerations in Analyzing Disease with Recurrent Events
Fan Xia, PHD
Roche, China
Statistical Scientist